Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chronic viral coinfections differentially affect the likelihood of developing long COVID
Michael J. Peluso, Tyler‐Marie Deveau, Sadie E. Munter, et al.
Journal of Clinical Investigation (2022) Vol. 133, Iss. 3
Open Access | Times Cited: 146

Showing 1-25 of 146 citing articles:

Distinguishing features of long COVID identified through immune profiling
Jon Klein, Jamie Wood, Jillian R. Jaycox, et al.
Nature (2023) Vol. 623, Iss. 7985, pp. 139-148
Open Access | Times Cited: 416
The immunology of long COVID
Daniel M. Altmann, Emily M. Whettlock, Siyi Liu, et al.
Nature reviews. Immunology (2023) Vol. 23, Iss. 10, pp. 618-634
Open Access | Times Cited: 250
SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)
Amy D. Proal, Michael B. VanElzakker, Soo Aleman, et al.
Nature Immunology (2023) Vol. 24, Iss. 10, pp. 1616-1627
Open Access | Times Cited: 171
ME/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature
Anthony L. Komaroff, W. Ian Lipkin
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 164
Long COVID: pathophysiological factors and abnormalities of coagulation
Simone Turner, Asad Khan, David Putrino, et al.
Trends in Endocrinology and Metabolism (2023) Vol. 34, Iss. 6, pp. 321-344
Open Access | Times Cited: 139
Why we need a deeper understanding of the pathophysiology of long COVID
Akiko Iwasaki, David Putrino
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 4, pp. 393-395
Open Access | Times Cited: 84
Vaccines and therapeutics for immunocompromised patients with COVID-19
Shmuel Shoham, Carolina Batista, Yanis Ben Amor, et al.
EClinicalMedicine (2023) Vol. 59, pp. 101965-101965
Open Access | Times Cited: 84
Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative
Hector Bonilla, Michael J. Peluso, Kathleen E. Rodgers, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 58
Long COVID: a review and proposed visualization of the complexity of long COVID
Rubeshan Perumal, Letitia Shunmugam, Kogieleum Naidoo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 58
Thromboinflammation in long COVID—the elusive key to postinfection sequelae?
Leo Nicolai, Rainer Kaiser, Konstantin Stark
Journal of Thrombosis and Haemostasis (2023) Vol. 21, Iss. 8, pp. 2020-2031
Open Access | Times Cited: 51
SARS-CoV-2 and innate immunity: the good, the bad, and the “goldilocks”
Benjamín L. Sievers, Mark T. K. Cheng, Kata Csiba, et al.
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 171-183
Open Access | Times Cited: 44
Spontaneous, persistent, T cell–dependent IFN-γ release in patients who progress to Long Covid
Benjamin A. Krishna, Eleanor Y. Lim, Marina Metaxaki, et al.
Science Advances (2024) Vol. 10, Iss. 8
Open Access | Times Cited: 43
Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infection
Michael J. Peluso, Dylan Ryder, Robert R. Flavell, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 754
Open Access | Times Cited: 34
Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease
Felicity Liew, Claudia Efstathiou, Sara Fontanella, et al.
Nature Immunology (2024) Vol. 25, Iss. 4, pp. 607-621
Open Access | Times Cited: 33
Mechanisms of long COVID and the path toward therapeutics
Michael J. Peluso, Steven G. Deeks
Cell (2024)
Open Access | Times Cited: 23
The immunology of systemic lupus erythematosus
George C. Tsokos
Nature Immunology (2024) Vol. 25, Iss. 8, pp. 1332-1343
Closed Access | Times Cited: 20
Iron dysregulation and inflammatory stress erythropoiesis associates with long-term outcome of COVID-19
Aimee L. Hanson, Matthew P. Mulè, Hélène Ruffieux, et al.
Nature Immunology (2024) Vol. 25, Iss. 3, pp. 471-482
Open Access | Times Cited: 18
Pathophysiological, immunological, and inflammatory features of long COVID
Karen Böhmwald, Benjamín Diethelm‐Varela, Linmar Rodríguez-Guilarte, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 17
Identification of an immunological signature of long COVID syndrome
Gisella Guerrera, Manolo Sambucci, Eleonora Timperi, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1
Multimodal Molecular Imaging Reveals Tissue-Based T Cell Activation and Viral RNA Persistence for Up to 2 Years Following COVID-19
Michael J. Peluso, Dylan Ryder, Robert R. Flavell, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 35
Cognitive dysfunction in post‐COVID‐19 condition: Mechanisms, management, and rehabilitation
Marika C. Möller, Kristian Borg, Christer Janson, et al.
Journal of Internal Medicine (2023) Vol. 294, Iss. 5, pp. 563-581
Open Access | Times Cited: 35
Autoantigen profiling reveals a shared post-COVID signature in fully recovered and long COVID patients
Aaron Bodansky, Chung‐Yu Wang, Aditi R. Saxena, et al.
JCI Insight (2023) Vol. 8, Iss. 11
Open Access | Times Cited: 34
Detrimental effects of COVID-19 in the brain and therapeutic options for long COVID: The role of Epstein–Barr virus and the gut–brain axis
Kenji Hashimoto
Molecular Psychiatry (2023) Vol. 28, Iss. 12, pp. 4968-4976
Open Access | Times Cited: 34
Acute and post-acute sequelae of SARS-CoV-2 infection: a review of risk factors and social determinants
Chumeng Wang, Akshara Ramasamy, Monica Verduzco‐Gutierrez, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 33
Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges
Dimitrios Tsilingiris, Natalia G. Vallianou, Ιrene Karampela, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10458-10458
Open Access | Times Cited: 30
Page 1 - Next Page

Scroll to top